A detailed history of Tang Capital Management LLC transactions in Allakos Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 378,552 shares of ALLK stock, worth $109,780. This represents 0.03% of its overall portfolio holdings.

Number of Shares
378,552
Previous 45,262 736.36%
Holding current value
$109,780
Previous $29,000 1479.31%
% of portfolio
0.03%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.62 - $1.5 $206,639 - $499,935
333,290 Added 736.36%
378,552 $458,000
Q3 2024

Nov 14, 2024

BUY
$0.54 - $0.92 $24,441 - $41,641
45,262 New
45,262 $29,000
Q4 2022

Feb 14, 2023

SELL
$5.66 - $8.42 $4.95 Million - $7.37 Million
-875,426 Reduced 66.15%
447,967 $3.77 Million
Q4 2021

Feb 14, 2022

BUY
$8.55 - $111.89 $11.3 Million - $148 Million
1,323,393 New
1,323,393 $13 Million

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $24.6M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.